Hormoclib 125mg Capsule (Palbociclib)
Hormoclib 125mg Capsule (Palbociclib)

Hormoclib 125mg Capsule (Palbociclib)

prescriptionImage Prescription Required

Manufactured By

Abbott

Pack Of

21

Salt Composition

Palbociclib

Storage

Store below 30°C

  • Quality-Assured Medicines
  • Verified Suppliers
  • Secure & Protective Packaging
  • Worldwide Delivery

Safe and Secure


Your health and safety are our top priority. All our medicines are sourced from trusted suppliers, thoroughly tested, and approved for use. We follow strict quality control standards to ensure every product is safe, effective, and reliable. You can enquire knowing your wellness is in good hands.

ALL SUBSTITUTES

Palbace 125mg Capsule

Palbace 125mg Capsule

Palbocib 125mg Capsule

Palbocib 125mg Capsule

Palbolieva 125mg Capsule

Palbolieva 125mg Capsule

Primcyv 125mg Capsule

Primcyv 125mg Capsule

Cydekin 125mg Capsule

Cydekin 125mg Capsule

Ciclib 125mg Capsule

Ciclib 125mg Capsule

Palboxen 125mg Capsule

Palboxen 125mg Capsule

Overview

The Hormoclib 125mg Capsule contains palbociclib, an oral targeted anticancer medicine that inhibits cyclin-dependent kinases 4 and 6 (CDK4/6). These enzymes help cells progress through the cell cycle. Blocking them can slow the growth of hormone-receptor-positive breast cancer cells. The Palbociclib 125mg capsule is used with endocrine therapy for selected patients with HR-positive, HER2-negative advanced or metastatic breast cancer.

The endocrine partner may be an aromatase inhibitor or fulvestrant depending on menopausal status, previous treatment, and clinical setting. Hormoclib 125mg Capsule is a prescription medicine and requires regular blood-count monitoring because neutropenia is common. The exact formulation matters: capsules and tablets can have different food instructions, so patients should follow the specific pack insert and oncologist’s directions.

Quick Product Facts

FieldPublication wording
BrandHormoclib
Active ingredientPalbociclib
Strength / presentation125 mg
FormCapsule
Medicine classCDK4/6 inhibitor
Manufacturer / marketerAbbott
Pack21 capsules
PrescriptionYes

Uses and Indications

The Hormoclib 125mg Capsule contains palbociclib, an oral targeted anticancer medicine that inhibits cyclin-dependent kinases 4 and 6 (CDK4/6). These enzymes help cells progress through the cell cycle. Blocking them can slow the growth of hormone-receptor-positive breast cancer cells. The Palbociclib 125mg capsule is used with endocrine therapy for selected patients with HR-positive, HER2-negative advanced or metastatic breast cancer.

The endocrine partner may be an aromatase inhibitor or fulvestrant depending on menopausal status, previous treatment, and clinical setting. Hormoclib 125mg Capsule is a prescription medicine and requires regular blood-count monitoring because neutropenia is common. The exact formulation matters: capsules and tablets can have different food instructions, so patients should follow the specific pack insert and oncologist’s directions.

How Hormoclib 125mg Capsule Works

Palbociclib capsule selectively inhibits cyclin-dependent kinases 4 and 6 (CDK4/6). These kinases phosphorylate the retinoblastoma protein and help cells move from the G1 phase into the S phase of the cell cycle. In HR-positive, HER2-negative breast cancer, blocking CDK4/6 can slow cell-cycle progression and enhance the effect of endocrine therapy. Bone-marrow precursor cells are also sensitive to this pathway, which is why neutropenia is a frequent treatment-limiting toxicity.

Clinical Evidence for Hormoclib 125mg Capsule

Evidence context: The studies below are pivotal or widely cited evidence supporting the Palbociclib 125mg capsule in major treatment settings. Trial results should not be interpreted as a guarantee of benefit for an individual patient, and exact eligibility must match the current approved indication and oncology guideline.

Side Effects of Hormoclib 125mg Capsule

Hormoclib 125mg Capsule may cause side effects, and their frequency varies by indication, dose, combination regimen, and patient population. The list below highlights clinically important effects rather than assigning a single percentage across different trials.

Common side effects

  • Neutropenia
  • Leukopenia
  • Fatigue
  • Infections
  • Nausea
  • Stomatitis / mouth sores
  • Hair thinning
  • Diarrhea

Serious effects requiring prompt medical attention

  • Febrile neutropenia / serious infection
  • Severe bone-marrow suppression
  • Interstitial lung disease / pneumonitis

Critical Safety Warning

Neutropenia is the principal dose-limiting toxicity and can lead to serious infection. Interstitial lung disease/pneumonitis has also been reported. Severe cytopenias require treatment interruption, dose reduction, or discontinuation according to the label.

Hormoclib 125mg Capsule Dosage and How To Take It

The standard starting dose is 125 mg orally once daily for 21 consecutive days, followed by 7 days off treatment, creating a 28-day cycle, in combination with appropriate endocrine therapy. Dose reductions for toxicity are commonly 100 mg once daily and then 75 mg once daily. The Palbociclib 125mg capsule is taken with food; tablet formulations have different food instructions, so the formulation on the pack matters. Premenopausal/perimenopausal women receiving an aromatase inhibitor or fulvestrant generally also receive an LHRH agonist.

Administration guidance: Take the Hormoclib 125mg Capsule exactly according to the prescribed 28-day cycle, commonly once daily for 21 consecutive days followed by 7 days without the palbociclib 125mg capsule. Because this product is a capsule, follow the capsule-specific instructions; palbociclib 125mg capsules are generally taken with food. Swallow capsules whole and do not open, crush, or chew them. Take the dose at approximately the same time each day. Blood counts are checked before and during treatment, particularly early cycles. The oncologist may delay palbociclib 125mg capsule treatment, interrupt it or reduce the dose for neutropenia or other toxicity. Avoid grapefruit products and discuss all new medicines before starting them.

Hormoclib 125mg Capsule Missed Dose

If a dose is missed or vomiting occurs after a dose, do not take an additional dose that day. Take the next dose at the regularly scheduled time.

Safety Advice for Hormoclib 125mg Capsule

CategoryStatusGuidance
PregnancyAvoidCan cause fetal harm. Use effective contraception for the label-specified period after treatment.
Male reproductive precautionsRequiredMale patients with partners of reproductive potential should follow label-based contraception guidance.
BreastfeedingAvoidDo not breastfeed during treatment and for the label-specified period after the final dose.
CBCEssentialCheck before treatment, early in therapy, and as clinically indicated because neutropenia is common.
LungsUrgent monitoringA new or worsening cough, dyspnea, or fever may indicate ILD/pneumonitis.
Liver/kidneySpecialist reviewSevere organ impairment can affect dosing decisions; follow the current label.

Monitoring During Hormoclib 125mg Capsule Treatment

CBC should be checked before treatment, at the start of each cycle, and around day 15 of the first two cycles, with additional monitoring as clinically indicated. Monitor for fever/infection and respiratory symptoms. Review hepatic impairment and CYP3A interactions.

Practical monitoring checklist

  • Complete blood count (CBC) at the label/protocol-recommended intervals

Hormoclib 125mg Capsule Fact Box

ParameterVerified / publication wording
GenericPalbociclib
BrandHormoclib
Manufacturer / marketerAbbott
Strength / presentation125 mg
FormCapsule
Drug classCDK4/6 inhibitor
Mechanism / targetPalbociclib selectively inhibits cyclin-dependent kinases 4 and 6 (CDK4/6).
Main indication contextThe Palbociclib 125mg capsule is used in combination with endocrine therapy for HR-positive, HER2-negative advanced or metastatic breast cancer. It may be combined with an aromatase inhibitor as initial endocrine-based therapy.
Biomarker / selectionHR-positive, HER2-negative breast cancer
AdministrationOral
Major warningSevere neutropenia/infection and interstitial lung disease
Pack21 capsules
StorageStore below 30°C.
Prescription requiredYes
Key evidencePALOMA-2, PALOMA-3

Hormoclib 125mg Capsule Drug Interactions

Drug / ClassRiskWhat To Do
Strong CYP3A inhibitorsIncrease palbociclib capsule exposureAvoid when possible; if unavoidable, use label-based dose reduction.
Strong CYP3A inducersCan reduce palbociclib exposureAvoid because efficacy may be reduced.
GrapefruitMay increase palbociclib 125mg exposureAvoid.
Sensitive CYP3A substratesPalbociclib capsules may increase their exposureReview narrow-therapeutic-index medicines and monitor appropriately.

FAQs About Hormoclib 125mg Capsule

What is the Hormoclib 125mg Capsule used for?

downArrowImg

The Hormoclib 125mg Capsule contains Palbociclib. Its approved uses depend on the cancer type, disease stage, biomarkers where relevant, previous treatment, and the current product label. The oncologist determines whether this medicine fits the treatment plan.

Is Hormoclib 125mg Capsule chemotherapy?

downArrowImg

This is not traditional cytotoxic chemotherapy; it is a targeted anticancer medicine.

Can the dose be decided from the tablet/capsule/vial strength?

downArrowImg

No. The strength printed on the pack is not necessarily the patient dose. Dosing may depend on indication, body size, kidney/liver function, treatment cycle, combination regimen, and toxicity.

What should I do if I develop a fever during Palbociclib 125mg treatment?

downArrowImg

Contact the oncology team urgently, especially with medicines that lower white blood cells. Fever during neutropenia can indicate a serious infection requiring rapid assessment.

Can I stop the Hormoclib 125mg treatment if side effects occur?

downArrowImg

Do not stop or reduce treatment on your own. Many oncology medicines have structured interruption and dose-reduction rules that allow toxicity to be managed safely.

Can I take supplements or herbal medicines with the Princyv 125mg treatment?

downArrowImg

Only after discussing them with the oncology team. Herbal products and OTC medicines can alter drug levels, bleeding risk, liver function, or treatment toxicity.

Why is the capsule taken for 21 days and then stopped for 7 days?

downArrowImg

The common 21-days-on/7-days-off schedule provides planned recovery time, particularly for blood counts. The exact schedule should match the oncologist's prescription.

Where can I confirm Palbociclib 125mg availability?

downArrowImg

Current stock and prescription fulfillment can be confirmed by visiting our website. Availability may vary by location, so it is advised to first check the stock before placing an order.

References

Marketer Details

Abbott

Author Details

logoImg

Written By:

Nonish Sharma

I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More


reviewerImg

Reviewed By:

Vaibhav Shakya

Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More

Last Updated: 17 Nov 2026 | 02:48 am (IST)

Want to know More

Check our Editor Policy

Disclaimer

Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.

Chat on WhatsApp